NAMI:NASDAQJinxin Technology Holding Company Analysis
Data as of 2026-04-19 - not real-time
$0.54
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Jinxin Technology Holding Company (NAMI) trades at roughly $0.54, far below its discounted cash‑flow fair value of about $4.05, suggesting a deep discount. Technical indicators are mixed: the 20‑day SMA sits above the 50‑day SMA but both remain under the 200‑day SMA, the RSI hovers near 47, and a bearish MACD histogram signals short‑term momentum weakness, while volume has been trending downwards. Fundamentals are weak: revenue growth is modest at 5 %, gross margin is under 20 %, and both operating and net margins are negative, with a sizable max drawdown of nearly 90 %. The recent announcement of a securities class‑action investigation adds legal uncertainty, and the company’s exposure to the Chinese education market brings heightened regulatory and geographic risk.
Given the extreme price discount, low beta, but high volatility (153 % 30‑day) and liquidity constraints, the stock sits at a crossroads: the valuation gap could attract contrarian interest, yet the operational losses, legal headwinds, and volatile trading environment make any upside speculative.
Given the extreme price discount, low beta, but high volatility (153 % 30‑day) and liquidity constraints, the stock sits at a crossroads: the valuation gap could attract contrarian interest, yet the operational losses, legal headwinds, and volatile trading environment make any upside speculative.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 5/10
Key Factors
- Bearish MACD and decreasing volume
- Proximity to recent support level
- Legal investigation adds downside risk
Medium Term
1–3 yearsNeutral
Model confidence: 4/10
Key Factors
- Significant valuation discount to DCF
- Low beta suggests limited market‑wide swings
- Continued operating losses and regulatory exposure
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- Persistent negative margins and cash‑flow deficits
- High volatility and liquidity constraints
- Elevated regulatory and legal risks in China
Key Metrics & Analysis
Financial Health
Revenue Growth5.30%
Profit Margin-6.63%
ROE-15.72%
ROA-8.16%
Debt/Equity2.46
P/B Ratio2.1
Op. Cash Flow$20.0M
Free Cash Flow$-6491000
Industry P/E19.3
Technical Analysis
TrendNeutral
RSI46.7
Support$0.45
Resistance$1.04
MA 20$0.63
MA 50$0.55
MA 200$0.81
MACDBearish
VolumeDecreasing
Fear & Greed Index90.21
Valuation
Fair Value$4.05
GradeUndervalued
TypeValue
Risk Assessment
Beta0.31
Volatility153.86%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.